Article Details
Retrieved on: 2022-01-19 21:31:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In company news, Vivos Therapeutics (VVOS) was 44% higher after reporting an 18-fold surge in the number of its home sleep apnea tests sold ...
Article found on: www.investorsobserver.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here